Drugs / uracil-tegafur
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00152191 | Oct 1996 → Oct 2007 | breast cancer | Taiho Pharmaceutical Co., Ltd. | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | uracil-tegafur | “oral uracil-tegafur (UFT)” PMID 19204202 ↗ Feb 2009 |
| Known as | UFT | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00152191 ↗ |
| Route | Oral | “uracil, tegafur was orally administered” NCT00152191 ↗ |